A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Tafenoquine is a promising new 8-aminoquinoline drug that may be useful for malaria prophylaxis in nonpregnant persons with normal glucose-6-phosphate dehydrogenase (G6PD) function. A randomized, double-blind, placebo-controlled chemoprophylaxis trial was conducted with adult residents of northern G...
Автори: | Hale, B, Owusu-Agyei, S, Fryauff, D, Koram, K, Adjuik, M, Oduro, A, Prescott, W, Baird, J, Nkrumah, F, Ritchie, T, Franke, E, Binka, F, Horton, J, Hoffman, S |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2003
|
Схожі ресурси
Схожі ресурси
-
Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana.
за авторством: Owusu-Agyei, S, та інші
Опубліковано: (2001) -
Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.
за авторством: Fryauff, D, та інші
Опубліковано: (2007) -
Seasonal malaria attack rates in infants and young children in northern Ghana.
за авторством: Baird, J, та інші
Опубліковано: (2002) -
Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
за авторством: Fryauff, D, та інші
Опубліковано: (1995) -
The antimalarial activity of tafenoquine in falciparum malaria
за авторством: White, NJ
Опубліковано: (2023)